fbpx Why we have a problem with vaccination coverage | Science in the net

Why we have a problem with vaccination coverage

Primary tabs

Read time: 2 mins

From the TELLME website

With the winter at the door, influenza epidemics are a problem to deal with. Every year they cause significant morbidity and mortality throughout Europe, especially in high-risk groups such as older people, individuals with chronic diseases, pregnant women and small children. In most of EU/EEA countries, uptake of seasonal influenza vaccination for these more endangered groups fall below the coverage threshold that the European Council of Ministers set at 75%.

The European Centre for Disease Prevention and Control  (ECDC) has conducted a systematic review to identify those elements that are responsible for such situation and the results of this study have just been released.

In elderly people, personalized postcards or phone calls seems to be effective, whilst misperceptions about the vaccine might be a barrier to receiving vaccination, thus highlighting the importance of an effective communication, necessary to debunk falsities and misrepresentations of vaccines. Other barriers to vaccination include social disadvantage, smoking, and lack of social support.

As for healthcare workers, education or promotion proved to be an effective approach in non-hospital settings but never raised vaccination rates above 90% within hospitals, in spite of being the most common interventions. Two observational studies from the USA also suggest that mandatory vaccine policies are more successful in improving rates of vaccination above 95%.

No good quality evidence on interventions was found for pregnant women, as well as for children.

At a general level, electronic reminders might help improving flu vaccination rates in adults if they can access the internet and use it regularly. Also, countries with high per capita income have significantly higher rates of coverage in adults and having to pay for vaccines is also a barrier, especially in the poorer countries.


Scienza in rete è un giornale senza pubblicità e aperto a tutti per garantire l’indipendenza dell’informazione e il diritto universale alla cittadinanza scientifica. Contribuisci a dar voce alla ricerca sostenendo Scienza in rete. In questo modo, potrai entrare a far parte della nostra comunità e condividere il nostro percorso. Clicca sul pulsante e scegli liberamente quanto donare! Anche una piccola somma è importante. Se vuoi fare una donazione ricorrente, ci consenti di programmare meglio il nostro lavoro e resti comunque libero di interromperla quando credi.


prossimo articolo

My Portrait of Anthony Fauci

Anthony Fauci, at 85, has been called to testify before the Senate committee investigating the origins of the Covid-19 pandemic, in what feels like a settling of scores by the very party that, at the time, was recommending chloroquine as a defence. The eminent physician is once again at the centre of controversy, not least for choosing to invoke the Fifth Amendment rather than answer questions. Guido Poli, immunologist at the San Raffaele Hospital and president of Patto Trasversale per la Scienza, who worked with him for many years, recalls in this article Tony Fauci's battles in the history of American and international public health, from AIDS to the pandemic. The image is taken from the footage (public domain) of A. Fauci's hearing on 29 July 2026 before the Senate Homeland Security and Governmental Affairs Committee.

In recent days, Anthony (“Tony”) Fauci has once again become a prominent figure in the international media, and to some extent in Italy as well. As the physician-scientist who has played one of the leading roles in U.S. public health over the past several decades, he became known throughout the world during the darkest days of the COVID-19 pandemic. Having had the privilege and good fortune to work with him from 1986 to 1993, I would like to offer my personal account of the scientist and the man.